Drug Submissions

Submission Guidelines for Nutrition Products

Nutrition products undergo a similar review process as drug products, although the manufacturer must satisfy a different set of requirements to be considered for reimbursement according to the Maximum Allowable Reimbursement (MAR) mechanism and pricing schedule. In the case of nutrition products, a nutrition consultant first reviews the complete submission. As with drug products, the Committee to Evaluate Drugs (CED) as a whole is asked to make a final recommendation to the Ministry regarding the reimbursement of nutrition products. Please refer to the section IX of the Formulary for more information on MAR and to Part II: Drug Submission Review Process for more detail on the review process.

Part V of the Ontario Guidelines for Drug Submission and Evaluation, contains the following information:

• Submission Requirements
• Nutrition Product Work Sheets
• Definitions of Categories of Nutrition Products

See Also:

• Ontario Guidelines for Drug Submission and Evaluation
• Drug Submission Status
• Improving Patient Access to Drugs: Rapid Review Process
• Single Monthly Formulary Process
• Off-Formulary Interchangeability
• Ontario Guidelines for Economic Analysis of Pharmaceutical Products
• Submission Guidelines for Oncology Drugs
• Inter-Provincial Joint Oncology Drug Review Process
• Submission Guidelines for Diabetic Testing Agents
• Submission Guidelines for Nutrition Products
• New Submission Deadline Dates for Multiple Source Products
• Guideline and Template Downloads